FAST DOWNLOAD
Who was Francisco Lopera? Learn about the biography of the Colombian neurologist and details of his personal life as well as the cause of his death.
The death of Francisco Lopera, a 73-year-old Colombian neurologist, who dedicated his life to studying Alzheimer’s, especially the hereditary form known as the “paisa mutation” , was recently announced. Learn about his biography.
Relatives of the renowned scientist announced his death on September 10 due to advanced cancer. Weeks earlier he had announced his retirement to spend his last days with his family.
Francisco Lopera: What is his biography?
Francisco Lopera Restrepo , born in Santa Rosa de Osos on February 9, 1951 and died in Medellín on September 10, 2024 at the age of 73 , was a Colombian neurologist and scientist. He stood out for his research on Alzheimer’s disease; diagnosing the genes that cause the disease early and those that can prevent its onset.
In his career in neurological medicine, he conducted research and studies on the genetics and variants of Alzheimer’s disease. He discovered the paisa mutation variant , characterized by a mixture of neurodegeneration and dementia, and published his findings in the journal Nature .
In 2024, he was awarded the Potamkin Prize , awarded by the American Academy of Neurology and the American Brain Foundation, considered a Nobel for those who have dedicated themselves to neuroscience.
Lopera’s career
Among Lopera’s main achievements and contributions are:
In Alzheimer’s research , Lopera led the Antioquia Neurosciences Group for more than 40 years. Through pioneering research, he identified the “Paisa Mutation,” a genetic mutation that causes early Alzheimer’s in a large family in Antioquia.
Lopera published numerous studies in renowned scientific journals , contributing significantly to global knowledge about Alzheimer’s; making him one of the most recognized figures in the world of scientific studies.
He was also a professor and director of the Department of Neuroscience at the University of Antioquia, where he trained numerous generations of neurologists and scientists.
His legacy in Alzheimer’s research has left a profound mark on the scientific community and has opened new avenues for the treatment and understanding of this disease.
